BioAgilytix Secures Significant New Investment from Global Investor Cinven to Fuel Continued Long-Term Growth

The Latest News from BioAgilytix

19 November, 2020

Jim Datin is Highlighted in TBJ Talking About BioAgilytix’ Performance in 2020 and Beyond

In this news article, our CEO Jim Datin discusses with Triangle Business Journal about BioAgilytix’ performance and the challenges they have experienced in 2020.

Read More

30 October, 2020

BioAgilytix Bioanalytical Lab Welcomes the Phadia 200 to Its Hamburg Laboratory

HAMBURG, Germany — BioAgilytix is thrilled to announce the addition of a new diagnostics tool to their growing list of cutting-edge bioanalysis instruments. With the help of this innovative instrument,…

Read More

29 October, 2020

Governor Cooper Announces 878 New Jobs as BioAgilytix Chooses Durham for Major Expansion

Bioanalytical life science company to invest $61.5 million RALEIGH: BioAgilytix Labs, LLC, a leading life science testing company, will create 878 jobs and invest $61.5 million in Durham, Governor Roy…

Read More

8 October, 2020

TBJ Reveals the 2020 Fast 50 Award Winners

BioAgilytix has recently been awarded the 2020 Fast 50 Award by Triangle Business Journal as one of the fastest-growing private companies within our region.

Read More

22 September, 2020

BioAgilytix Welcomes Kennon Broadhurst as Vice President of Global Marketing to Its Commercial Leadership Team

September 22, 2020-Durham, NC-BioAgilytix Labs is pleased to announce the appointment of Kennon Broadhurst to its Commercial Leadership team as Vice President of Global Marketing. Kennon joins BioAgilytix after having…

Read More

22 September, 2020

BioAgilytix Welcomes Kennon Broadhurst as Vice President of Global Marketing to Its Commercial Leadership Team

PRNewswire covers the news of welcoming Kennon Broadhurst to the BioAgilytix team, bringing with him over 26 years of experience in sales, marketing and product commercialization experience.

Read More

24 August, 2020

BioAgilytix’s Durham, North Carolina Laboratory Receives Certificate of Accreditation from COLA

BioAgilytix has received its Certificate of Accreditation for high complexity testing in the diagnostic immunology specialty from the Commission on Office Laboratory Accreditation (COLA) for its U.S. facility in Durham, North Carolina.

Read More

19 August, 2020

BioAgilytix Welcomes Marianne Scheel Fjording, Ph.D. to Team as Scientific Officer

Dr. Fjording will be based at BioAgilytix’s European laboratory in Hamburg, Germany and will provide scientific and regulatory oversight to BioAgilytix’s team in the development and implementation of strategies for bioanalytical assay development and regulated assay validation.

Read More

3 August, 2020

BioAgilytix Rebrands Its Cambridge Biomedical Diagnostic Testing Division to BioAgilytix Diagnostics

The new name is reflective of BioAgilytix’s plan, which was set forth following its acquisition of Boston-based Cambridge Biomedical in late 2019, to fully integrate Cambridge Biomedical’s clinical and diagnostic testing capabilities into BioAgilytix’s global service offerings.

Read More